Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Vorpahl

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Current Treatment Options in Cardiovascular Medicine|September 16, 2010
Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of strokeSaami K Yazdani, Marc Vorpahl, Elena Ladich, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Do we really understand pimecrolimus?Marc Vorpahl, Aloke V Finn, Masataka Nakano, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 22, 2011
The bioabsorption process: tissue and cellular mechanisms and outcomesMarc Vorpahl, Aloke V Finn, Masataka Nakano, et al.
The Journal of Invasive Cardiology|August 16, 2018
Feasibility of Transradial Access for Coronary Interventions Via Percutaneous Angioplasty of the Radial Artery in Cases of Functional Radial OcclusionMichael Schulte-Hermes, Oliver Klein-Wiele, Marc Vorpahl, et al.
Journal of Geriatric Cardiology : JGC|February 26, 2019
Peritonitis and pneumoperitoneum after successful emergency pericardiocentesis in the case of a Chilaiditi syndromeMichael Schulte-Hermes, Oliver Klein-Wiele, Marc Vorpahl, et al.
JACC. Cardiovascular Imaging|May 16, 2009
One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosisGaku Nakazawa, Marc Vorpahl, Aloke V Finn, et al.
European Heart Journal|June 3, 2008
Unusual use of a standard percutaneous transluminal coronary angioplasty balloon catheter to the rescueMarc Vorpahl, Karl-Ludwig Laugwitz, Bernhard Zrenner, et al.
Biomed Research International|May 23, 2015
Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve ReplacementTill Koehler, Michael Buege, Heinrich Schleiting, et al.
Circulation|March 30, 2005
Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible miceSabine Merl, Cornelia Michaelis, Birgit Jaschke, et al.
BMC Cardiovascular Disorders|June 17, 2018
Temporarily increased stroke rate after Takotsubo syndrome: need for an anticoagulation?Nadine Abanador-Kamper, Lars Kamper, Judith Wolfertz, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Current Treatment Options in Cardiovascular Medicine|September 16, 2010
Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of strokeSaami K Yazdani, Marc Vorpahl, Elena Ladich, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Do we really understand pimecrolimus?Marc Vorpahl, Aloke V Finn, Masataka Nakano, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 22, 2011
The bioabsorption process: tissue and cellular mechanisms and outcomesMarc Vorpahl, Aloke V Finn, Masataka Nakano, et al.
The Journal of Invasive Cardiology|August 16, 2018
Feasibility of Transradial Access for Coronary Interventions Via Percutaneous Angioplasty of the Radial Artery in Cases of Functional Radial OcclusionMichael Schulte-Hermes, Oliver Klein-Wiele, Marc Vorpahl, et al.
Journal of Geriatric Cardiology : JGC|February 26, 2019
Peritonitis and pneumoperitoneum after successful emergency pericardiocentesis in the case of a Chilaiditi syndromeMichael Schulte-Hermes, Oliver Klein-Wiele, Marc Vorpahl, et al.
JACC. Cardiovascular Imaging|May 16, 2009
One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosisGaku Nakazawa, Marc Vorpahl, Aloke V Finn, et al.
European Heart Journal|June 3, 2008
Unusual use of a standard percutaneous transluminal coronary angioplasty balloon catheter to the rescueMarc Vorpahl, Karl-Ludwig Laugwitz, Bernhard Zrenner, et al.
Biomed Research International|May 23, 2015
Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve ReplacementTill Koehler, Michael Buege, Heinrich Schleiting, et al.
Circulation|March 30, 2005
Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible miceSabine Merl, Cornelia Michaelis, Birgit Jaschke, et al.
BMC Cardiovascular Disorders|June 17, 2018
Temporarily increased stroke rate after Takotsubo syndrome: need for an anticoagulation?Nadine Abanador-Kamper, Lars Kamper, Judith Wolfertz, et al.
Pageof 7